Ribon Therapeutics Funding: $75M Raised, Series B (2019)
Ribon Therapeutics is based in Cambridge, MA. It has raised $75M in total funding. Latest round: Series B.
Ribon Therapeutics funding overview
Ribon Therapeutics is based in Cambridge, MA. Ribon Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2019. The round record for Ribon Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include AbbVie, Bristol Myers Squibb, Johnson & Johnson, Novartis, Takeda, Deerfield Management and 5 others. 11 distinct backers are named across the disclosed rounds.
Ribon Therapeutics at a glance
Total raised
$75M
Latest round
Series B
Latest round date
January 2019
Headquarters
Cambridge, MA
Notable investors
AbbVie, Bristol Myers Squibb, Johnson & Johnson, Novartis, Takeda, Deerfield Management, U.S. Venture Partners, Avego BioScience Capital
Frequently asked about Ribon Therapeutics funding
How much has Ribon Therapeutics raised?
Ribon Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Ribon Therapeutics?
AbbVie, Bristol Myers Squibb, Johnson & Johnson, Novartis, Takeda, Deerfield Management are named among the investors backing Ribon Therapeutics.
What was the latest Ribon Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2019.
Where is Ribon Therapeutics based?
Ribon Therapeutics is based in Cambridge, MA.
When did Ribon Therapeutics last raise?
The last disclosed Ribon Therapeutics round closed in January 2019 at Series B.
Totals shown for Ribon Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
